Transcarent
Workforce health benefits platform — completed $621M Accolade merger; serves 20M+ members across 1,700+ employer/health-plan clients.
What is Transcarent?
Transcarent is a workforce-health and care-experience platform founded in 2020 by Glen Tullman, the former CEO of Livongo (which sold to Teladoc for $18.5B in 2020). Headquartered in San Francisco, the company helps self-insured employers and health plans deliver a unified, AI-powered member experience across pharmacy, surgery, cancer care, weight health, mental health, and primary/specialty care. In April 2025 Transcarent completed a $621M cash merger with Accolade — combining one of the largest direct-to-employer benefits-navigation platforms with Transcarent's health-experience stack. The combined organization now serves more than 20M members and 1,700+ employer/health-plan clients. Pre-merger, Transcarent raised $450M+ across 4 rounds — $200M Series C in 2022 and a $126M Series D in May 2024 led by General Catalyst and 7wireVentures, valuing the company at $2.2B before the Accolade transaction. Snezana Mahon, Pharm.D., was promoted to President in late 2024.
Mission & values
Make it easy for everyone to get great healthcare — give members and the employers who cover them a single trusted front door for every health and care decision.
Qualifications
Transcarent hires across engineering (data, ML/AI, platform, mobile, infrastructure), product, design, clinical (RNs, NPs, MDs, pharmacists, behavioral-health clinicians), care navigation, member services, sales, customer success, marketing, finance, legal, and people. Most non-clinical roles are US-remote-friendly with the SF HQ + Plymouth Meeting PA (legacy Accolade hub) + a major Indian operations footprint absorbed via the merger. Clinical roles (telehealth providers, care advocates) require state-by-state licensure aligned with member populations and are remote-eligible within those states. Apply via transcarent.com/careers.
Leadership
Glen Tullman
Chief Executive Officer
Founder & CEO of Transcarent; previously founder/CEO of Livongo (NASDAQ: LVGO, sold to Teladoc for $18.5B in 2020). Also founder of 7wireVentures and 62 Ventures.
Snezana Mahon, PharmD
President
Promoted to President in late 2024; previously COO at Transcarent. Pharm.D. by training with 20+ years in pharmacy benefits and member-experience operations.
Rajeev Singh
Vice Chair (former Accolade CEO)
Co-founder and former CEO of Accolade; transitioned to Vice Chair after the April 2025 merger.
Hiring process
-
1
Application
Apply via transcarent.com/careers and select a role that matches your skill set.
-
2
Recruiter screen
Initial conversation to confirm fit, location, and licensure (for clinical roles).
About 3 days
-
3
Hiring manager interview
Role-specific deep-dive with the team's manager.
About 5 days
-
4
Functional / clinical loop
Multi-round interviews — system design + coding for eng; case studies for product/GTM; clinical skills review for licensed providers.
About 10 days
-
5
Offer + credentialing
Final values fit, comp discussion, and (for clinical roles) state-by-state credentialing kickoff.
About 7 days
Funding
Awards & recognition
-
$621M merger with Accolade completed · 2025
Transcarent
-
$2.2B valuation at $126M Series D · 2024
General Catalyst / 7wireVentures
-
Glen Tullman recognized as a healthcare visionary (Livongo founder) · 2020
Industry
-
20M+ members and 1,700+ clients on combined platform · 2025
Transcarent
Company information
- Industry: Health Tech / Workforce Benefits
- Location: San Francisco, CA, USA
- Founded: 2020
- Employees: 3,000
- Website: transcarent.com ↗
- LinkedIn: Company page ↗
- X / Twitter: Profile ↗